Aid Cuts Open Gaps in HIV and Malaria Care

More than 20 million people are at risk of losing access to life-saving HIV medicines as funding cuts disrupt health systems, according to the World Health Organization.

WHO said 75 of 106 surveyed countries reported disruption in at least one essential health service area after recent suspensions and reductions in official development assistance for health. The agency said the strain reaches beyond HIV to malaria, tuberculosis, vaccine-preventable disease and neglected tropical diseases.

The figures describe a crisis that is quieter than a hospital collapse and harder to see in real time. Clinics may still open their doors. Staff may still show up. The failure appears in missing diagnostics, late deliveries, shrinking outreach and medicine inventories that no longer cover the next month.

WHO Director-General Tedros Adhanom Ghebreyesus said in March that cuts to direct U.S. funding through USAID, the U.S. Centers for Disease Control and Prevention and other agencies had already caused severe disruption to malaria diagnostics, medicines and insecticide-treated bed nets. If that continues, he said, the world could see 15 million additional malaria cases and 107,000 deaths this year alone.

He said the suspension of most funding to the U.S. President’s Emergency Plan for AIDS Relief had caused an immediate stop to HIV treatment, testing and prevention services in more than 50 countries. Eight countries, he said, were already facing substantial disruption to antiretroviral therapy and some would run out of medicines in the coming months.

WHO also warned that disruptions to HIV programmes could lead to more than 10 million additional HIV cases and 3 million HIV-related deaths over time, reversing two decades of progress. On tuberculosis, Tedros said 27 countries in Africa and Asia were facing breakdowns in diagnosis, treatment, surveillance and community work, while nine countries had reported failing procurement and supply chains for TB drugs.

The geography of the crisis changes the language around it. In donor capitals, the debate has often been framed as budget discipline or program redesign. In WHO briefings, the language is continuity of care and service disruption. In refugee settlements and rural districts, the issue is simpler: whether the nurse still has the drug, the test, the lab reagent or the fuel to reach the next village.

WHO said more than 2,600 health facilities in 12 humanitarian crises had already suspended services at least partially, or were about to do so. It also said almost 24 million people living in humanitarian crises were at risk of losing access to essential health services. In Cox’s Bazar in Bangladesh, Tedros said diagnosis and treatment of hepatitis C had been disrupted along with disease surveillance, laboratory services, procurement and salaries for health workers.

The health effects will not land all at once. Malaria prevention fails first in the background, with fewer bed nets and diagnostics. HIV programmes begin to slip when testing stops, outreach shrinks and treatment interruptions grow. Tuberculosis becomes harder to trace when community health workers disappear from the chain. Measles surveillance weakens before the outbreak curve rises.

WHO said the Global Measles and Rubella Network, a system of more than 700 laboratories funded solely by the United States, faced imminent shutdown. Tedros said that threat was arriving while measles was already resurging, with 57 large or disruptive outbreaks recorded last year.

The agency has avoided treating the problem as an accounting dispute. Its guidance page now links countries and communities to emergency recommendations on sustaining services during drug shortages, stockouts and treatment interruptions. The message is that ministries may have to shift quickly from normal delivery to triage.

There are early signs of replacement funding, but not at the scale health officials say is needed. Euronews reported this week that the European Commission pledged €700 million to the Global Fund while also lowering its own contribution, a sign that donor support remains politically fragile.

Tedros said countries that relied on U.S. financing will need to raise domestic health spending where they can, while other donors step in. That transition, he said, must be orderly if lives are not to be lost in the gap.

The immediate marker is not next year’s mortality table but the next procurement cycle. Several countries, WHO said, could run out of antiretroviral medicines within months.